From the article above''The lack of a flow rate is what we think caused the brutal sell off on Wednesday.''I wonder how many of them had to put their heads together to come up with that pearl of wisdom
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
